BUZZ-MAIA Biotechnology plunges after $30 million share sale

Reuters03-03
BUZZ-<a href="https://laohu8.com/S/MAIA">MAIA Biotechnology</a> plunges after $30 million share sale

** Drug developer MAIA Biotechnology's MAIA.A shares plunge 29% to $1.47 premarket

** MAIA late on Monday announced pricing of $30 million public offering

** Co sold 20 million shares at $1.50 apiece, a 27.5% discount to stock's last close

** Offering led by healthcare-dedicated investors alongside existing shareholders - MAIA

** Proceeds will be used to conduct clinical trials and for working capital, general purposes

** Konik Capital Partners was sole book-running manager for offering

** MAIA had 38.7 million outstanding shares as of March 2, according to offering prospectus

** Lone analyst covering MAIA rates it "buy" and has $12.14 PT - data compiled by LSEG

** As of last close, MAIA stock up 35.3% YTD

(Reporting by Arasu Kannagi Basil in Bengaluru)

((ArasuKannagi.Basil@thomsonreuters.com;))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment